Literature DB >> 8676341

Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action.

M Evers1, C Poujade, F Soler, Y Ribeill, C James, Y Lelièvre, J C Gueguen, D Reisdorf, I Morize, R Pauwels, E De Clercq, Y Hénin, A Bousseau, J F Mayaux, J B Le Pecq, N Dereu.   

Abstract

A series of omega-undecanoic amides of lup-20(29)-en-28-oic acid derivatives were synthesized and evaluated for activity in CEM 4 and MT-4 cell cultures against human immunodeficiency virus type 1 (HIV-1) strain IIIB/LAI. The potent HIV inhibitors which emerged, compounds 5a, 16a, and 17b, were all derivatives of betulinic acid (3beta-hydroxylup-20(29)-en-28-oic acid). No activity was found against HIV-2 strain ROD. Compound 5a showed no inhibition of HIV-1 reverse transcriptase activity with poly(C).oligo(dG) as template/primer, nor did it inhibit HIV-1 protease. Additional mechanistic studies revealed that this class of compounds interfere with HIV-1 entry in the cells at a postbinding step.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676341     DOI: 10.1021/jm950670t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Anti-AIDS agents 82: synthesis of seco-(3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) derivatives as novel anti-HIV agents.

Authors:  Jian Tang; Keduo Qian; Bei-Na Zhang; Ying Chen; Peng Xia; Donglei Yu; Yi Xia; Zheng-Yu Yang; Chin-Ho Chen; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2010-04-29       Impact factor: 3.641

2.  Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking.

Authors:  Ping Lan; Wan-Na Chen; Zhi-Jian Huang; Ping-Hua Sun; Wei-Min Chen
Journal:  J Mol Model       Date:  2010-10-27       Impact factor: 1.810

3.  Exploration of the antiplatelet activity profile of betulinic acid on human platelets.

Authors:  Andreas G Tzakos; Vassiliki G Kontogianni; Maria Tsoumani; Eleni Kyriakou; John Hwa; Francisco A Rodrigues; Alexandros D Tselepis
Journal:  J Agric Food Chem       Date:  2012-07-03       Impact factor: 5.279

4.  Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase.

Authors:  T Akihisa; J Ogihara; J Kato; K Yasukawa; M Ukiya; S Yamanouchi; K Oishi
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

5.  Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors.

Authors:  Hua Zhao; Shaletha S Holmes; Gary A Baker; Suresh Challa; Himangshu S Bose; Zhiyan Song
Journal:  J Enzyme Inhib Med Chem       Date:  2011-10-10       Impact factor: 5.051

6.  Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase.

Authors:  Robert J Visalli; Hannah Ziobrowski; Kameswara R Badri; Johnny J He; Xiugen Zhang; Sri Ranjini Arumugam; Hua Zhao
Journal:  Bioorg Med Chem Lett       Date:  2015-06-06       Impact factor: 2.823

7.  Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368.

Authors:  P Chatterjee; S A Kouzi; J M Pezzuto; M T Hamann
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

Review 8.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

9.  Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.

Authors:  Keduo Qian; Donglei Yu; Chin-Ho Chen; Li Huang; Susan L Morris-Natschke; Theodore J Nitz; Karl Salzwedel; Mary Reddick; Graham P Allaway; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

10.  Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.

Authors:  Jizhen Li; Masuo Goto; Xiaoming Yang; Susan L Morris-Natschke; Li Huang; Chin-Ho Chen; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2015-11-11       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.